about
Identification of transcriptional regulators in the mouse immune systemTranscriptional Regulation of Mononuclear Phagocyte DevelopmentCCR7 and IRF4-dependent dendritic cells regulate lymphatic collecting vessel permeability.Comparison of gene expression profiles between human and mouse monocyte subsetsLy6Chi monocyte recruitment is responsible for Th2 associated host-protective macrophage accumulation in liver inflammation due to schistosomiasis.LXR promotes the maximal egress of monocyte-derived cells from mouse aortic plaques during atherosclerosis regression.CD103+ pulmonary dendritic cells preferentially acquire and present apoptotic cell-associated antigen.GM-CSF controls nonlymphoid tissue dendritic cell homeostasis but is dispensable for the differentiation of inflammatory dendritic cells.HDL and Glut1 inhibition reverse a hypermetabolic state in mouse models of myeloproliferative disorders.Disruption of Glut1 in Hematopoietic Stem Cells Prevents Myelopoiesis and Enhanced Glucose Flux in Atheromatous Plaques of ApoE(-/-) Mice.MHC II+ resident peritoneal and pleural macrophages rely on IRF4 for development from circulating monocytesMinimal differentiation of classical monocytes as they survey steady-state tissues and transport antigen to lymph nodesRegulation of the migration and survival of monocyte subsets by chemokine receptors and its relevance to atherosclerosis.Embryonic and adult-derived resident cardiac macrophages are maintained through distinct mechanisms at steady state and during inflammation.Deciphering the transcriptional network of the dendritic cell lineageUnderstanding macrophage diversity at the ontogenic and transcriptomic levels.Complement Factor H Inhibits CD47-Mediated Resolution of Inflammation.A PDGFRα-Mediated Switch toward CD9high Adipocyte Progenitors Controls Obesity-Induced Adipose Tissue Fibrosis.The Heterogeneity of Ly6Chi Monocytes Controls Their Differentiation into iNOS+ Macrophages or Monocyte-Derived Dendritic Cells.Promoting macrophage survival delays progression of pre-existing atherosclerotic lesions through macrophage-derived apoE.The transcriptional landscape of αβ T cell differentiation.ATP-binding cassette transporters and HDL suppress hematopoietic stem cell proliferation.Conventional dendritic cells at the crossroads between immunity and cholesterol homeostasis in atherosclerosis.Sall1 is a transcriptional regulator defining microglia identity and function.Emerging roles of neural guidance molecules in atherosclerosis: sorting out the complexity.Macrophage apoptosis exerts divergent effects on atherogenesis as a function of lesion stage.Lysosomal Cholesterol Hydrolysis Couples Efferocytosis to Anti-Inflammatory Oxysterol Production.Cholesterol Accumulation in Dendritic Cells Links the Inflammasome to Acquired Immunity.Maintenance of Macrophage Redox Status by ChREBP Limits Inflammation and Apoptosis and Protects against Advanced Atherosclerotic Lesion Formation.Enhanced dendritic cell survival attenuates lipopolysaccharide-induced immunosuppression and increases resistance to lethal endotoxic shock.Macrophage Origin, Metabolic Reprogramming and IL-1 Signaling: Promises and Pitfalls in Lung CancerEnhanced immune system activation and arterial inflammation accelerates atherosclerosis in lupus-prone mice[HDL and its transporters ABCA1 and ABCG1 regulate innate immunity and hematopoietic stem cell proliferation]Bcl-x inactivation in macrophages accelerates progression of advanced atherosclerotic lesions in Apoe(-/-) miceFree cholesterol transfer to high-density lipoprotein (HDL) upon triglyceride lipolysis underlies the U-shape relationship between HDL-cholesterol and cardiovascular diseaseTargeted invalidation of SR-B1 in macrophages reduces macrophage apoptosis and accelerates atherosclerosisAutophagy inhibition blunts PDGFRA adipose progenitors' cell-autonomous fibrogenic response to high-fat diet
P50
Q24609000-47438926-CC9D-4E55-BAD4-A06B43DCCB30Q26779410-6E975BA3-019A-4A7C-A218-2933AF0E8DAEQ27329950-63148086-D8FF-4FF3-9AC3-F1A049535F0FQ33608738-F55E1C91-6707-4020-B8F4-F0B06A474E84Q34075772-BBF4B361-BE1B-44DF-9E98-4C438A4EC3F5Q34360087-BF547931-5ED5-4611-B20A-F9BCE1C64B43Q35208349-65A698FD-97EA-43B4-9A5D-827C556283C0Q36398839-20050FEC-24B0-4448-A0FB-7E102281824EQ36603504-0C297FEA-606A-48EC-9548-EEBB1C182B67Q36776429-10317A23-2F24-4E04-98D4-759998F0BE80Q37272125-F7DCE971-0FB8-4019-957E-3411C8B04E27Q37286595-24140AD8-52F2-4F6F-8248-8AC336C6E79DQ37435783-87183CE9-242B-4E06-85E6-96522F7CBB32Q37581780-42556C46-B961-4CD8-9B4D-D5026B760944Q37700905-391DB07D-99F4-4495-B488-64606AC854F2Q38260569-056298CB-DAB6-4364-90BE-E33EC15D0259Q38929333-27AD5547-342C-4AC5-AD4D-38CED77EECC6Q38953153-C444CD5D-4C8D-4426-BF67-4AFC62D02F1CQ40172102-3CD1D049-98A7-43A2-846F-E12054B82479Q40819017-CC5B283E-448C-42EE-9CF3-B50A8C6CDAFAQ40905788-D69234C9-813A-49D6-BD3F-79DF39DBCABCQ41789790-4E95716C-0C43-4C42-AB7E-06541DB061EEQ46043752-585542D7-8AEB-47B3-84D7-F1D93F0604C0Q48264747-9A23F912-7973-4B6A-BEF4-5E98C752F89DQ51074959-3F4FE564-6B6F-484E-A74B-9E7D14522FA9Q51754500-0DE835B7-B337-4773-AE98-DBD2E2337082Q52663732-359D1DF0-B000-48EA-ABEA-0128DA206C99Q52772414-F5AC695F-7CB9-47B1-8BD6-AA14744FFAACQ52913918-E58B0CB8-26EB-49FF-8C85-D99FC162A049Q54534377-5F766D4A-D311-4011-B97A-EEC64ECF026EQ64071901-FB25A3CA-96F9-49C0-A9CA-9ED338497DC2Q80187091-08BC1786-0ED9-4393-A638-E57DC41E3EF9Q83385414-786D586F-E832-4D88-93ED-A8CB5D2B57ECQ83556112-E2CF3AE7-B4E5-4FCF-9D0A-1C9B4710D19AQ91999503-2AE11398-43C8-47E7-AD8D-0B828B9C6682Q92231080-911A6F5B-9F3B-4C11-B60A-F7C6233ED581Q93008706-EB52DE3B-764D-4890-A881-65C7D75D8335
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Emmanuel L. Gautier
@ast
Emmanuel L. Gautier
@en
Emmanuel L. Gautier
@es
Emmanuel L. Gautier
@sl
type
label
Emmanuel L. Gautier
@ast
Emmanuel L. Gautier
@en
Emmanuel L. Gautier
@es
Emmanuel L. Gautier
@sl
prefLabel
Emmanuel L. Gautier
@ast
Emmanuel L. Gautier
@en
Emmanuel L. Gautier
@es
Emmanuel L. Gautier
@sl
P1053
E-2259-2017
P106
P1153
16645608300
P21
P31
P3829
P496
0000-0003-2976-7566